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Abstract 
The human amniotic membrane (HAM) contains two cell types from different embryological origins. Human amnion 
epithelial cells (hAECs) are derived from the embryonic ectoderm, while human amnion mesenchymal stromal cells 
(hAMSCs) are derived from the embryonic mesoderm. In this study, we localized, isolated, quantified and 
phenotypically characterized HAM-derived cells and analysed their in vitro differentiation potential towards 
mesodermal cell lineages. Human amnion-derived cells were isolated and characterized by flow cytometry. 
Immunohistochemistry and quantitative real-time reverse transcription-polymerase chain reaction studies were 
performed for the analysis of multipotentiality. Immunophenotypic characterization of both cell types demonstrated 
the presence of the common, well-defined human mesenchymal stem cell (MSC) markers (CD90, CD44, CD73, 
CD166, CD105, CD29), as well as the embryonic stem-cell markers SSEA-4 and STRO-1. Phenotypes of both cell 
populations were maintained from passages P0 to P9. The assessment of multilineage potential demonstrated that the 
hAMSCs showed greater adipogenic and chondrogenic potential. Both populations had the ability to retain their 
capacity for differentiation during culture passages from P0 to P4. Our data demonstrate the successful localization 
and isolation of hAMSCs and hAECs from the HAM. Both cell populations possessed similar immunophenotype. 
However, they differed in cell yield and multipotential for differentiation into the major mesodermal lineages. Our 
functional differentiation studies demonstrated that hAMSCs possess a much greater mesodermal differentiation 
capacity than hAECs. These considerations will be important for use of these cells for cell therapy. 
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Within the bone marrow stroma, a subset of non-hematopoietic cells referred to as mesenchymal stem 
cells (MSC) exists. These cells can be expanded ex vivo and induced, both in vitro or in vivo, to 
terminally differentiate into at least seven cell types: osteocytes, chondrocytes, adipocytes, tenocytes, 
myotubes, astrocytes and hematopoietic-supporting stroma [Minguell et al., 2000]. Three criteria define 
all types of stem cells: self-renewal, multipotency and the ability to reconstitute a tissue in vivo. Human 
MSCs, which are probably responsible for normal tissue renewal, as well as for response to injury [Tsai et 
al., 2007], can be isolated from bone marrow, peripheral blood, umbilical cord blood, umbilical cord, 
amniotic fluid, amniotic membrane, placenta, fat, skin, vasculature and muscle tissues. 
Multipotent MSCs are a promising cell resource for tissue engineering and cell-based therapeutics 
because of their ability to self-renew and differentiate into specific functional cell types [Tsai et al., 
2007]. The list of tissues with the potential for tissue engineering is increasing because of recent progress 
in stem-cell biology [Bianco and Robey, 2001]. 
The use of bone marrow, which is the traditional tissue source for adult MSCs, however, has some 
limitations. One of the most important is accessibility. The procedure required to obtain bone marrow is 
invasive, painful and associated with morbidity, the number of MSCs obtained is low and the potential to 
proliferate and differentiate diminishes as the donor's age increases [Baksh et al., 2007; Soncini et al., 
2007; Ilancheran et al., 2009; Wei et al., 2009]. Thus, the identification of alternative MSC sources is 
necessary. 
The human amniotic membrane (HAM) develops from extra-embryonic tissue and consists of a foetal 
component, the chorionic plate and a maternal component, the deciduas. The HAM is consists of an 
epithelial monolayer, a thick basement membrane and an avascular stroma [Jin et al., 2007; Niknejad et 
al., 2008]. The inner layer, the amnion, consists of a single layer of ectodermally derived epithelium 
uniformly arranged on the basement membrane, one of the thickest membranes found in any human 
tissue, and a collagen-rich mesenchymal layer [Wilshaw et al., 2006]. The HAM contains two cell types 
from different embryological origins [Alviano et al., 2007; Wolbank et al., 2007]. The human amnion 
epithelial cells (hAECs) are derived from embryonic ectoderm [Tamagawa et al., 2008], which forms a 
continuous monolayer in contact with the amniotic fluid. Human amnion mesenchymal stromal cells 
(hAMSCs) are derived from embryonic mesoderm [Tamagawa et al., 2008] and are sparsely distributed in 
the stroma underlying the amnion epithelium [Bilic et al., 2008]. This foetal tissue expresses only 
moderate levels of the major histocompatibility complex (MHC) class I and MHC class II antigens on its 
surface. Therefore, hAECs and hAMSCs seem to be immune-privileged, thus suitable for allo-
transplantation and regenerative medicine [Kim et al., 2009; Wei et al., 2009]. Bailo et al. 2004 isolated 
and characterized amnion and chorion cells from human full-term placentae, suggesting that both cell 
types represent a useful source of progenitor cells with potential applications for cell therapy and 
transplantation procedures. 
Because foetal tissues are routinely discarded post-partum, HAMs have proved to be abundant, 
inexpensive and easily obtained with a virtually limitless availability, negating any need for mass tissue 
banking [Wilshaw et al., 2006; Hennerbichler et al., 2007; Toda et al., 2007; Niknejad et al., 2008; Chang 
et al., 2010]. Therefore, the HAM represents a very useful source of progenitor cells for a variety of 
applications. Because human embryos are not sacrificed for the isolation of progenitor cells from HAMs, 
the current controversies associated with the use of human embryonic stem cells can be avoided [Toda et 
al., 2007; Kim et al., 2009; Chang et al., 2010; Insausti et al., 2010]. 
In the present study, we performed the localization, isolation, quantification and phenotypic 
characterization of HAM-derived cells (hAECs and hAMSCs) and analysed their in vitro differentiation 
potential towards the osteogenic, adipogenic and chondrogenic cell lines useful for regenerative medicine 
and cell therapy. 
Materials and Methods 
Harvest and Preparation of HAMs 
Human placentas from 12 healthy donor mothers were obtained from caesarean sections performed at the 
Hospital Materno Infantil-Teresa Herrera in A Coruña, Spain. All mothers gave written informed consent 
prior to collection. This study was approved by the Ethics Committee of Clinical Investigation of Galicia 
(Spain). Under stringent sterile conditions the harvested placentas were placed in 199 Medium 
(Invitrogen S.A., Barcelona, Spain) with antibiotics: cotrimoxazol (50 µg/ml; Soltrim®, Almirall-
Prodesfarma S.A., Barcelona, Spain), vancomycin (50 µg/ml; Vancomicina Hospira®, Laboratorio 
Hospira S.L., Madrid, Spain), amykacin (50 µg/ml; Amikacina Normon®, Laboratorios Normon S.A., 
Madrid, Spain) and B amphotericin (5 µg/ml; Fungizona®, Bristol-Myers Squibb S.L., Madrid, Spain). 
The HAM was carefully separated from the chorion and immediately processed, following washes with 
0.9% NaCl solution three to five times to remove blood and mucus. 
Isolation and Culture of Human Amnion-Derived Cells: hAMSCs and hAECs 
The HAMs were then processed following the protocol of Soncini et al. 2007. The HAM was cut into 
approximately 2 × 2 cm2 pieces and transferred into an enzymatic digestion buffer containing 2.4 U/ml of 
dispase (Gibco, Madrid, Spain) in phosphate buffered saline (PBS) and incubated at 37°C for 7 min. The 
digested tissue was centrifuged and the supernatant was discarded. The tissue was then subjected to a 
second enzymatic digestion containing 0.75 mg/ml of type I clostridial collagenase (Gibco) and 20 µg/ml 
of deoxyribonuclease I (DNAse I; Sigma–Aldrich, Quimica S.A., Madrid, Spain) in RPMI 1640 (Lonza, 
Barcelona, Spain) culture medium for 3 h at 37°C. Following this digestion the resulting cell suspension 
was filtered through a sterile 70 µm filter (BD Biosciences, Madrid, Spain). The collected cells were 
designated as hAMSCs. Non-digested amnion fragments were incubated with a solution containing 
0.25% trypsin–EDTA (Sigma–Aldrich) at 37°C for 2–3 min. The resulting cell suspension, containing 
hAECs was centrifuged at 200g for 10 min. The cells were resuspended in Dulbecco's modified Eagle 
medium (DMEM; Sigma–Aldrich) with 20% foetal bovine serum (FBS; Lonza) and 1% penicillin–
streptomycin (P/E; Gibco) and seeded into 162 cm2 culture flasks. Both hAECs and hAMSCs cells were 
cultured in a humidified 5% CO2 atmosphere at 37°C until 70% confluent. The cells were then recovered 
and expanded to obtain the appropriate number of cells for further experiments. Non-adherent cells were 
removed after 48 h of culture.  
Quantification of Cells 
The isolated hAMSCs and hAECs were counted using a Neubauer Chamber. Trypan blue dye (0.4%; 
Sigma–Aldrich, St. Louis, MO, USA) was used to assess cell viability. 
Cell Characterization by Flow Cytometry 
HAM-derived cells were harvested by trypsinization, washed and centrifuged at 300g for 8 min. The cells 
were counted and 2 × 105  cells were transferred to fluorescence-activated cell sorting (FACS) 
polypropylene tubes before flow cytometry. The antibodies listed in Table I were used for these 
experiments. Optimal amounts of monoclonal antibodies (mAbs) were determined and added to each tube 
for 40 min at 4°C in darkness. Most antibodies were conjugated with fluorescein isothiocyanate (FITC), 
phycoerithrin (PE), or allophicocianine (APC) and were specific for the human markers associated with 
mesenchymal and hematopoietic lineages. When the use of a secondary antibody was necessary, the cells 
were incubated for 30 min at 4°C in darkness to allow its binding to the primary antibody. A control tube 
for each of the chromogens used contained equivalent amounts of isotype standards. A minimum of 
10,000 cell events per assay were acquired on a FACsCalibur flow cytometer (BD Biosciences). Data 
were analysed using Cell Quest software (BD Biosciences). Statistical evaluations were performed using 
the Mann–Whitney U-test. Results are expressed as percent positive, that is, mean ± standard deviation 
(mean ± SD). Differences were considered statistically significant when P < 0.05. 
Table I. Antibodies Used for Cell Characterization by Flow Cytometry 
Antibody Specificity Clone Source 
    
R-PE-CD29 β1 Integrin MAR4 BD Pharmingen 
R-PE-CD34 Hemopoietic progenitor cell antigen 1 (HPCA1) 581 BD Pharmingen 
FITC-CD44 HCAM IM7 BD Pharmingen 
FITC-CD45 Leukocyte common antigen (LCA) HI30 BD Pharmingen 
PE-CD73 Ecto-5′-nucleotidase AD2 BD Pharmingen 
PE-Cy5-CD90 Thy-1 5E10 BD Pharmingen 
FITC-CD105 Endoglin SN6 Serotec 
APC-CD117 c-kit, SCFR YB5.B8 BD Pharmingen 
R-PE-CD166 ALCAM 3A6 BD Pharmingen 
Fibroblast Fibroblast-specific antigen 1B10 Sigma Aldrich Quimica 
SSEA-4 Stage-specific embryonic antigen 4 MC-813-70 R&D Systems 
STRO-1 Stromal antigen 1 NS1-Ag4-1 Developmental Studies Hybridoma Bank 
    
 
In Vitro Differentiation Studies 
Adipogenesis. 
hAECs and hAMSCs from the passages P0 to P4 were detached using trypsin–EDTA and 
1.5 × 105 cells/cm2 were cultured in a one-well chamber slide in growth medium until confluent. 
Adipogenesis was induced by culturing in Bullekit Adipogenic Differentiation Medium (Lonza), 
following the manufacturer's instructions. Cells were fixed for histological analysis using 4% 
paraformaldehyde. 
Osteogenesis 
HAM-derived cells from passages P0 to P4 were detached using trypsin–EDTA and 1.5 × 105 cells/cm2 
were cultured in a one-well chamber slide in growth medium until confluent. Osteogenesis was induced 
by culturing for 3 weeks in hMSC Bullekit Osteogenic Differentiation Medium (Lonza). The culture 
medium was changed every 2–3 days. Cells were fixed in 4% paraformaldehyde for histological analysis. 
  
Chondrogenesis 
Chondrogenesis was assessed by micropellet formation as described by Johnstone et al. 1998, with some 
modifications. HAM-derived cells (5 × 105 cells/cm2) from passages P0 to P4 were detached using 
trypsin–EDTA and centrifuged at 300g for 10 min. The resulting pellet was cultured in chondrogenic 
differentiation medium [Arufe et al., 2009], DMEM with 15% FBS. The medium was supplemented with 
5 mg/ml ascorbic acid (AA), 1/1,000 monotioglycerol (MTG) and 1% P/E during the first 2 days to 
promote the induction of chondrogenesis. The medium was then replaced by DMEM with 15% knockout 
serum (Gibco), 1% P/E and supplemented with 1 µl/ml AA, 10 µM dexamethasone (DEXA), 6 µl/ml 
Transferrin, 1 × 107 M retinoic acid (RA) and 1 ng/ml of recombinant human transforming growth factor-
β3 (rHuTGF-β3; Prospec-Tany Technogene Ltd., Rehovot, Israel) for 21 days. The medium was changed 
every 2–3 days. The micropellets were embedded in paraffin and the presence of hyaline cartilage-
characteristic molecules [collagen type II (Coll II) and proteoglycans] was detected using the histological 
and immunohistochemical techniques described below. 
For controls for each differentiation assay, hAECs and hAMSCs were cultured in DMEM medium 
containing 20% FBS and P/E for 21 days. The controls were also evaluated using the same histological 
and immunohistochemical analyses. 
Histological Analyses 
To evaluate chondrogenesis, 4-µm thick paraffin sections of the micropellets were deparaffinized in 
xylol, rehydrated in a graded series of ethanol, and stained with hematoxylin and eosin (H&E), Masson´s 
trichrome and toluidine blue (for proteoglycans). To evaluate osteogenesis, the presence of calcium 
deposits was determined using Alizarin Red stain according to the standard protocol. To evaluate 
adipogenesis, the presence of cytoplasmic lipid droplets in the cultures was visualized using Oil Red O 
stain. Quantification of the staining for Alizarin Red and Oil Red O was performed using analiSIS® 
software (version D; Olympus, Barcelona, Germany). 
Immunohistochemical Analyses 
For the immunohistochemical evaluation of chondrogenesis, 4-µm thick paraffin sections, deparaffinized, 
and hydrated as described above, were incubated with mAbs to detect the presence of Coll I (Abcam, 
Cambridge, UK) and Coll II (Neomarker, Barcelona, Spain), and with a polyclonal antibody to detect 
aggrecan (Agg; C-20; Santa Cruz Biotechnology, Heidelberg, Germany; Table II). To facilitate exposure 
of the epitopes, sections were pre-treated with proteinase K (Sigma–Aldrich). The peroxidase/DAB 
ChemMateTM DAKO EnVisionTM detection kit (Dako, Barcelona, Spain) was used to determine 
antigen–antibody interactions. Localization of MSC-derived amniotic cells by immunofluorescence was 
performed using antibodies listed in Table II. Negative staining controls omitted the primary mAb. 
Quantification of the immunostaining for Coll I and II and Agg was performed using analiSIS® software 
(version D; Olympus, Barcelona, Germany). 
Table II. Antibodies Used for Immunoenzymatic and Immunofluorescence Studies 
Specificity Clone Source 
 
Inmunoenzymatic 
Type I collagen COL-1 Abcam 
Type II collagen 6B3 Neomarker 
Aggrecan (C-20) Polyclonal Santa Cruz Biotechnology 
Inmunofluorescence 
CD44 HCAM Santa Cruz Biotechnology 
CD90 SE10 BD Pharmingen™ 
CD105-FITC SN6 Serotec 
CD271 ME20.4 Sigma Aldrich 
   
  
RNA Extraction 
Isolation of total RNA from cell cultures was performed using Trizol Reagent (Invitrogen), following the 
manufacturer's protocol. From each cell culture, 2.5 × 105 cells were extracted for RNA isolation. Total 
RNA was further processed by reverse transcription-polymerase chain reaction (RT-PCR) or stored at 
−80°C until used. RNA integrity was confirmed by 2% agarose gel electrophoresis stained with ethidium 
bromide. RNA also was assessed for quantity at 260 nm using a NanoDrop™ spectrophotometer (Thermo 
Scientific, Madrid, Spain). The A260/A280 ratio was calculated to verify quality and purity. 
cDNA Synthesis 
RT-PCR was accomplished from 1 µg of total RNA using SuperScript™ First-Strand Synthesis System 
for RT-PCR (Invitrogen) in a total volume of 20 µl in a Thermocycler (Gene Amp PCR System 9700, 
Applied Biosystems, Madrid, Spain). One microgram of total RNA, 25 nM Oligo(dT), 0.5 mM of dNTP 
mix, and 3 µl of DEPC-treated water were denatured at 65°C for 5 min and chilled on ice for at least 
1 min. In addition, 2 µl of 10× RT buffer, 5 mM MgCl2, 0.01 M DTT, and 40 U of RNaseOUT 
Recombinant Ribonuclease Inhibitor were mixed, collected by centrifugation, and incubated at 25°C for 
2 min. After incubation, 50 U of SuperScript™ RT were added and incubated at 25°C for 10 min, 42°C 
for 50 min and 70°C for 15 min in a Thermocycler (Gene Amp PCR System 9700, Applied Biosystems). 
Finally, the samples were chilled on ice and incubated with 2 U of RNAse H for 20 min at 37°C before 
proceeding to amplification of the target cDNA. 
Samples were stored at −20°C before target cDNA was amplified. Positive and negative controls were 
included in each experiment. RNA extraction, RT-PCR assay setup and post RT-PCR product analysis 
were carried out in separate dedicated rooms to prevent cross-contamination. 
Quantitative Real-Time RT-PCR Analysis (qRT-PCR) 
qRT-PCR analysis was performed, using the primers and conditions shown in Table III, on a 
LightCycler® 480 Instrument (Roche, Mannheim, Germany) using LightCycler 480 SYBR Green I 
Master (Roche). 
Table III. Primer Sequences, Conditions and Annealing Temperatures of Real-Time Reverse Transcription-Polymerase Chain 
Reaction (RT-PCR) for Amplification of mRNA Human Genes Specific for Adipogenic, Osteogenic and Chondrogenic 
Differentiation 
Primer Sequence Position 
Length 
(mer) 
%GC 
Annealing 
temperature (°C) 
Amplicon 
(bp) 
       
Sox9 2F 5′-gtacccgcacttgcacaac-3′ 750–768 19 58 61 72 
Sox9 2R 5′-tcgctctcgttcagaagtctc-3′ 801–821 21 52   
COL2A1 3F 5′-gtgtcagggccaggatgt-3′ 247–264 18 61 61 116 
COL2A1 3R 5′-tcccagtgtcacagacacagat-3′ 341–362 22 50   
Agg 1F 5′-gcctacgaagcaggctatga-3′ 1891–1910 20 55 61 136 
Agg 1R 5′-gcacgccataggtcctga-3′ 2009–2026 18 61   
FABP4 1F 5′-ggatgataaactggtggtgga-3′ 401–421 21 48 61 125 
FABP4 1R 5′-cacagaatgttgtagagttcaatgc-3′ 501–525 25 40   
APM1 1F 5′-ggtgagaaaggagatccaggt-3′ 280–300 21 52 61 147 
APM1 1R 5′-tgctgagcggtatacataggc-3′ 406–426 21 52   
LPL 1F 5′-agaacatcccattcactctgc-3′ 1491–1511 21 48 61 107 
LPL 1R 5′-ccatttgagcttcaacatgagt-3′ 1576–1597 22 41   
ALP 1F 5′-gacggacccgtcactctc-3′ 1169–1186 18 67 61 109 
ALP 1R 5′-gtgcccgtggtcaattct-3′ 1260–1277 18 56   
OP 1F 5′-cgcagacctgacatccagt-3′ 646–664 19 58 61 136 
OP 1R 5′-ggctgtcccaatcagaagg-3′ 763–781 19 58   
RPLP 1F 5′-cctggaagtccaactacttcctta-3′ 260–283 24 46 61 143 
RPLP 1R 5′-catcagcaccacagccttc-3′ 384–402 19 58   
       
 
%GC, percentage of guanine–cytosine; Sox9, sex-determining region Y-box 9; Col2A1, collagen type II alpha 1; Agg, aggrecan; 
FABP4, fatty acid-binding protein 4; APM1, adiponectine; LPL, lipoprotein lipase; ALP, alkaline phosphatase; OP, osteopontin; 
RPLP, 60S acidic ribosomal protein P0 (housekeeping gene). 
 
 
The PCR reaction consisted of 10 µl of Master Mix (2×), 0.35 µM of each forward and reverse primer, 
cDNA template and PCR-grade water up to a final volume of 20 µl in the LightCycler 480 Multiwell 
Plate 96. An initial activation at 95°C for 10 min was followed by an amplification target sequence of 50 
cycles at 95°C for 10 s, 61°C for 5 s, and 72°C 7 s. For the melting curve analysis, one cycle at 95°C for 
5 s, 65°C for 1 min, and 97°C for 1 s was used. The final cooling step was at 40°C for 20 s. 
The use of 2% agarose gel electrophoresis, stained with SYBR® Safe DNA gel stain (Invitrogen™), 
of all PCR products revealed a single band that corresponded to the single-amplified products as predicted 
by the PCR melting curve analysis. 
PCR primers for mRNA amplification were carefully designed using the web-based ProbeFinder 
software (Universal ProbeLibrary Design Center, 2008) accessible at www.universalprobelibrary.com or 
at the Roche Applied Science home page (2008, www.roche-applied-science.com). 
The selection of a suitable housekeeping gene was performed using the Human Endogenous Control 
Gene Panel (TATAA Biocenter, Göteborg, Sweden). The Excel macro named GeNorm VBA applet for 
Microsoft Excel (2006, available at http://medgen.ugent.be/∼jvdescomp/genorm/) was used to determine 
the gene(s) with the most correlated expression in the set of samples. The housekeeping gene selected was 
RPLP (60s acidic ribosomal protein P0). Data analysis utilized the LightCycler 480 Relative 
Quantification software (Roche). Relative levels of expression were calculated by the 2−ΔΔCt method 
[Livak and Schmittgen, 2001]. Data were normalized against the value obtained in controls grown in 
DMEM culture medium at time 0, which was considered equal to 1, and were measured as relative 
expression levels (REL). 
DNA Sequencing Analysis 
At least one PCR product coming from each real-time PCR experiment was used as a template DNA. 
PCR products were purified by an enzymatic method (ExoSAP-IT, Amersham Biosciences, Madrid, 
Spain). DNA sequencing was performed in a reference facility on the ABI 3100 (Applied Biosystems) 
using Big Dye terminators. Forward and Reverse specific primers were used (these primers were the same 
as for the qRT-PCR experiments, see Table III). 
Other Procedures 
Standard procedures for manipulation of nucleic acids were essentially those of Sambrook et al. 1989. 
Statistical Analysis 
All statistical analyses were performed using SPSS 16.0 software for Windows; P-values <0.05 were 
considered to be statistically significant. 
Results 
Localization of HAM-Derived Stem Cells 
To ascertain the histological localization of HAM-derived stem cells, four healthy HAMs were examined 
using immunofluorescence. The co-localization of the CD44, CD90, CD105 and CD271 stem-cell 
markers were assessed. We did not observe any cells in which co-localization of three and/or four stem-
cell markers occurred. However, we frequently observed co-localization of double markers. We found 
CD105 co-located with CD90, CD44 co-located with CD90 and CD271 co-localized with CD44 (Fig. 1). 
Most cells labelled with the different stem-cell markers were hAMSCs from the thick basement 
membrane, although in some membranes we observed hAECs, derived from the embryonic ectoderm, 
that were labelled only for the CD105 marker. The immunofluorescence results indicate that the HAM 
contains at least two different cell types having stem-cell characteristics. 
  
 
 
 
Figure 1. Immunofluorescence analysis of stem-cell marker expression of human amnion cells. Sections of four HAMs stained with 
H&E (A and E). Representative images of hAMSCs and hAECs that were stained with antibodies specific for CD44, CD90, CD105 
and CD271 (B–D and F–H) are shown. Nuclei were counterstained with 4',6-diamidino-2-phenylindole (DAPI). 
Immunofluorescence confirmed that hAMSCs were positive for CD44, CD90, CD105 and CD271, while hAECs were positive only 
for CD105. A thick basement membrane (BM) and cells from the extra-embryonic ectoderm (EC) are indicated. Circles highlight 
amnion cells from the basement membrane. 
Isolation of HAM-Derived Cells 
HAM-derived cells were isolated from full-term amnion after manual separation from the chorion. For 
cell isolation, we followed the protocol described by Soncini et al. 2007. This protocol resulted in the 
isolation of two distinct cell populations. One population had a fibroblast-like cell morphology and was 
considered to be hAMSCs derived from the embryonic mesoderm. The second population consisted of 
small-size cells that grew in a lattice with the typical quadrangular shape of epithelial cells and were 
considered to be hAECs derived from the embryonic ectoderm. After 2 days in culture, both hAECs and 
hAMSCs were attached to the culture flasks. Quantitative studies showed that this isolation protocol 
yielded 6.9 × 106 ± 8.8 × 106 hAECs (n = 3) and 2 × 106 ± 2.4 × 106 hAMSCs (n = 3). 
Phenotypical Characterization of HAM-Derived Cells 
Immunophenotypic analysis was performed to assess the expression of mesenchymal and hematopoietic 
markers in isolated hAECs and hAMSCs. This analysis was performed on cells after isolation at passages 
P0–P2. The expression profiles of these cells are shown in Table IV. Although we found markers specific 
for stem cells in both cell populations, there were no differences in expression profiles depending on the 
passage analysed. 
Table IV. Analysis of Hematopoietic and Standard Adult Stem-Cell Markers on Human Amnion Mesenchymal Stromal Cells 
(hAMSCs) and Human Amnion Epithelial Cells (hAECs) 
Marker hAMSCs % (mean ± SD) hAECs % (mean ± SD) 
   
CD29 82.16 ± 21.04 90.73 ± 7.55 
CD44 76.11 ± 20.16a 21.74 ± 21.32 
CD73 64.34 ± 19.21 80.88 ± 10.24a 
CD90 88.44 ± 11.47a 47.54 ± 30.15 
CD105 31.83 ± 29.8 11.52 ± 6.70 
CD166 44.36 ± 27.72 70.58 ± 31.97 
CD117 22.78 ± 16.68 14.31 ± 7.04 
SSEA-4 37.82 ± 40.03 61.91 ± 36.87 
STRO-1 1.29 ± 2.13 5.14 ± 5.08 
CD34 0.175 ± 0.39 0.02 ± 0.04 
   
 
a Means P-value <0.05 (Mann–Whitney U-test). 
  
FACS analysis demonstrated that CD90 (88.48% ± 11.49), CD44 (76.11% ± 20.16), CD73 
(64.34% ± 19.21), CD166 (44.36% ± 27.72), CD105 (31.83% ± 29.80), CD29 (82.16% ± 21.04) and 
CD117 (22.78% ± 16.68) are present in hAMSCs (n = 8). On the other hand, hAECs (n = 8) exhibit the 
presence of CD90 (47.54% ± 30.15), CD44 (21.74% ± 21.32), CD73 (80.88% ± 10.24), CD166 
(70.58% ± 31.97), CD105 (11.52% ± 6.7), CD29 (90.73% ± 7.55) and CD117 (14.31% ± 7.04). The 
hematopoietic markers CD34 and CD45 were absent in both populations, indicating no contamination 
with hematopoietic stem cells from the umbilical cord blood. The absence of fibroblasts also indicated 
lack of contamination from embryonic fibroblasts. 
When comparing the different markers among the two isolated populations, we observed that the 
expression levels of CD90 and CD44 were higher in hAMSCs than in hAECs (P = 0.012 and 0.001, 
respectively, Mann–Whitney U-test). However, CD73 showed higher levels of expression in hAECs than 
in hAMSCs (P = 0.015, Mann–Whitney U-test). There were no statistically significant differences among 
hAMSCs and hAECs in expression of the other markers. Interestingly, two embryonic stem-cell markers, 
SSEA-4 and STRO-1, were also found to be positive in both cell populations. The SSEA-4 marker was 
present at higher levels in the hAECs (61.91%) than in hAMSCs (37.82%; P > 0.05). The STRO-1 marker 
was also present at higher levels in hAECs (5.14%) than in hAMSCs (1.29%), although the differences 
were not significant statistically. 
This phenotypical characterization demonstrated that HAM-derived cells, hAMSCs and hAECs, have 
a cell-surface receptor expression pattern similar to that previously reported for bone marrow MSCs. 
Interestingly, we found that both populations retained their phenotypic characteristics for at least nine 
culture passages. 
In Vitro Differentiation Potential of hAMSCs and hAECs 
Isolated hAMSCs and hAECs were cultured under specific conditions to perform functional 
differentiation assays. We studied the potential of these cells to differentiate into multiple cells lineages, 
specifically, chondrocytes, adipocytes and osteocytes, as previously described in Materials and Methods 
Section. As expected the differentiation potential studies showed the existence of donor-dependent 
variance. 
Adipogenic differentiation was assessed by Oil Red O staining after 21 days of culture in adipogenic 
medium (Fig. 2). hAMSCs showed positive staining, with single adipocytic multivacuolar cells secreting 
lipid droplets. However hAECs displayed the absence or much weaker staining for lipids than hAMSCs. 
The percentage of cells with positive Oil Red O staining was 37 times higher in hAMSCs than in hAECs 
(P-value = 0.013, Mann–Whitney U-test). The same cells maintained in control medium (DMEM) 
exhibited almost no lipid deposits. 
 
 
 
Figure 2. Adipogenic differentiation (Dif Adipo) of human amnion mesenchymal stromal cells (hAMSCs) and human amnion 
epithelial cells (hAECs) with their respective controls (C hAMSC and C hAEC) grown for 21 days in Dulbecco's modified Eagle 
medium (DMEM). The presence of adipocytes was assessed by detection of lipid drops using Oil Red O (OR-O) stain. The presence 
of the calcium deposits characteristic of osteoblasts was detected using Alizarin Red (AR) stain (A). The percentage of cells positive 
for OR-O stain is expressed as the mean ± standard deviation; *Indicates P < 0.05 (B). The adipogenic differentiation potential was 
confirmed by qRT-PCR, comparing results to the corresponding control time zero (T0) and DMEM-only culture. T0 data represent 
the expression of the different lineage-specific genes at the start of the experiment when the cells had not been stimulated to 
differentiate. DMEM data represent the expression of the different lineage-specific genes in cells cultured for 21 days in DMEM 
medium alone. DIF data represent the expression of the different lineage-specific genes in cells after culture for 21 days in a 
differentiation medium. mRNA levels were measured by qRT-PCR as described in Materials and Methods Section. Data are 
expressed as mean ± standard error of the relative expression levels (REL). The results were normalized to values obtained for each 
cell population at the starting point of the experiment, which were considered to equal 1 (C). 
  
The osteogenic differentiation potential of HAM-derived cells was examined by determining the 
presence of calcification using Alizarin Red stain (Fig. 3). Both cell populations evidenced calcium 
deposition (hAMSCs: 13.63% and hAECs: 23.49% positive). Although hAECs manifested more intense 
staining levels these differences were not statistically significant. The same cells maintained in control 
medium presented an absence of calcium deposits. 
 
 
 
Figure 3. Osteogenic differentiation (Dif Osteo) of human amnion mesenchymal stromal cells (hAMSCs) and human amnion 
epithelial cells (hAECs) and their respective controls (C hAMSC and C hAEC) grown for 21 days in Dulbecco's modified Eagle 
medium (DMEM). The presence of calcium deposits characteristic of osteoblasts was detected using Alizarin Red (AR) stain (A). 
The percentage of cells positive for AR staining is expressed as the mean ± standard deviation (B). The osteogenic differentiation 
potential was confirmed by qRT-PCR (C). 
  
The ability to undergo chondrogenic differentiation was assessed by toluidine blue staining for 
proteoglycans. Agg and Coll I and II were detected by immunohistochemisry (Fig. 4). Chondrogenesis 
was observed in all the cell preparations that were analysed. However, there were differences in the 
chondrogenic differentiation assays between the cell populations. The percentage of positive staining for 
Coll II and Agg were statistically significantly higher in hAMSCs than in hAECs (P = 0.015 and 0.000), 
respectively; Mann–Whitney U-test). However, it is important to note that some micropellet structures of 
hAECs did not acquire the typical round shape of chondrogenic differentiation described by Johnstone et 
al. 1998. Coll II and proteoglycans were detected throughout the newly formed matrix, although 
immunodetection for Agg was weak in most samples. Staining for Coll I was also weak or absent. 
 
 
 
Figure 4. Chondrogenic differentiation (Dif Chondro) of human amnion mesenchymal stromal cells (hAMSCs) and human amnion 
epithelial cells (hAECs) and their respective controls (C hAMSC and hAEC) grown for 21 days in Dulbecco's modified Eagle 
medium (DMEM). Micropellets were stained with H&E, Masson's trichrome (MM), and toluidine blue (AT) for proteoglycans. 
Immunodetection of Agg (Ag-C20) and collagen type II (Col II) was performed to detect molecules characteristic of hyaline 
cartilage. Immunodetection for Col I was also assessed (A). The percentage of cells positive for Col I, Col II and Agg staining is 
expressed as the mean ± standard deviation (B). The chondrogenic differentiation potential was confirmed by qRT-PCR (C). 
*Indicates P < 0.05. 
Adipogenic, osteogenic and chondrogenic differentiation was also assessed by qRT-PCR. We studied 
the expression of some lineage-specific genes to determine which cell population, hAMSCs or hAECs, 
possessed the greater capability to differentiate. Expression levels of adiponectine (APM1), lipoprotein 
lipase (LPL) and fatty acid binding protein 4 (FABP4) were analysed for adipogenic differentiation. 
Expression levels of osteopontin (OP), and alkaline phosphatase (ALP) were analysed for osteogenic 
differentiation, and expression levels of Col II, Sox9 (sex determining region Y-box 9) and Agg were 
analysed for chondrogenic differentiation. RNA extracted from hAMSCs and hAECs following 
adipogenic, osteogenic and chondrogenic differentiation showed expression of all the lineage-specific 
genes analysed as shown in Figures 2C, 3C and 4C, with the exception being the lack of Agg in hAECs 
following chondrogenic differentiation. The expression of the RPLP housekeeping gene was assessed in 
all samples to analyse the integrity of the amplified cDNA. REL of each gene was quantified by qRT-
PCR. 
As shown in Figure 2C, lineage-specific genes for adipogenesis showed RELs from 13.05- to 22.21-
fold in hAMSCs and from 0.2- to 3.32-fold in hAECs, compared to the undifferentiated control cells. 
Lineage-specific genes for osteogenesis (Fig. 3C) showed REL between 6.1 × 102- and 1.1 × 103-fold in 
hAECs and from 2.1 × 103- to 2.9 × 103-fold in hAMSCs, compared to time 0 of differentiation control 
cells. The REL were always higher in adipogenesis and osteogenesis differentiation medium than in cells 
grown in DMEM for 21 days and in non-differentiated cells, with the exceptions of LPL and APM1 in 
hAECs. These results indicate that both populations were able to differentiate towards osteocyte-like 
cells; however, only hAMSCs underwent differentiation to the adipogenic lineage. In chondrogenic 
differentiation, both populations were able to differentiate towards chondrocyte-like cells and to express 
Coll II, Agg and Sox9, although their behaviours were slightly different (Fig. 4C). The hAMSCs, after 
culture in the chondrogenic differentiation medium, showed greater REL of the lineage-specific genes 
than did cells grown in DMEM for 21 days or in non-stimulated cells. In contrast, hAECs cultured in 
chondrogenic medium showed only a very slight increase in Coll II expression, but a decrease in Sox9 
and Agg compared to cells grown in DMEM for 21 days. These results indicate that hAMSCs could 
possess stronger chondrogenic differentiation than hAECs, because they express higher REL for Sox9 
(P = 0.046, Mann–Whitney U-test) and Agg (P > 0.05, Mann–Whitney U-test) than hAECs. 
Discussion 
The amniotic membrane is the innermost membrane surrounding the foetus. Because it arises from 
embryonic epiblast cells prior to gastrulation, it has been suggested that it may retain a reservoir of stem 
cells throughout pregnancy [Ilancheran et al., 2007]. In recent years, HAMs have been used as biologic 
dressings for ophthalmology, plastic surgery, dermatology, and gynecology procedures [Morton and 
Dewhurst, 1986; Meller et al., 2000; Santos et al., 2005; Rinastiti et al., 2006; Tejwani et al., 2007]. The 
isolation of hAMSCs and hAECs from HAMs as a tissue source of adult MSCs has recently received 
great interest in the fields of cell transplantation and regenerative medicine. 
In this report, we compare two distinct types of pluripotent cells isolated from HAMs to define their 
localization, isolated quantity, morphological and phenotypic characterization and multilineage 
differentiation potential. Our immunofluorescence studies indicated that the HAM contains two different 
cell types having stem-cell characteristics; hAMSCs from the thick basement membrane and hAECs from 
the single layer of ectodermally derived epithelium. For all HAM analysed, taking into account the 
amount of amniotic membrane used, the yield of hAECs was always higher than that of hAMSCs, 
indicating that the isolation and expansion protocol used produced a large number of hAECs in a short 
time. 
The hAMSCs showed the adherence to plastic and the fibroblast-like growth usually observed in 
MSCs from bone marrow. Furthermore, immunophenotypic characterization of these cells demonstrated 
the presence of the common well defined human MSC markers (CD90, CD44, CD73, CD166, CD105 
and CD29), previously described for bone marrow with the absence of the hematopoietic markers CD34 
and CD45, and the concomitant lack of fibroblast markers [Kobayashi et al., 2008; Mihu et al., 2009]. 
This antigen expression pattern is consistent with data previously published for stem cells isolated from 
various regions of the full-term placenta [Bailo et al., 2004; Barlow et al., 2008; Bilic et al., 2008; 
Kobayashi et al., 2008; Mihu et al., 2009]. 
Isolated hAECs grew in a lattice structure and had the quadrangular shape typical of epithelial cells. 
Because they were positive for the same markers as hAMSCs, hAECs also had an antigen expression 
profile characteristic of culture-expanded MSCs [Bilic et al., 2008]. Phenotypes of both cell populations 
were maintained from passages P0 to P9. It is important to note that although both populations, hAMSCs 
and hAECs, showed a similar cell-surface receptor expression pattern, there were many differences 
between them in cell shape and cell arrangement. This is in accordance with the results of Bilic et al. 
2008. These investigators also isolated these two populations and concluded that hAECs and hAMSCs in 
culture exhibited and maintained a similar marker profile for mesenchymal progenitors. 
Statistical analyses revealed that expression levels of CD90 and CD44 were higher in the population 
of hAMSCs than in hAECs, whereas CD73 was higher in hAECs than in hAMSCs, in agreement with 
published results [Bilic et al., 2008]. Ilancheran et al. 2007 showed that hAECs expressed surface markers 
that are normally present on embryonic stem and germ cells, in accordance with our data that indicates 
that both populations in culture express the SSEA-4 and STRO-1 markers of undifferentiated cells. Both 
of these embryonic stem-cell markers were present in greater quantities in hAECs than in hAMSCs, as 
previously described by Bilic et al. 2008, possibly indicating that hAECs could be in an earlier state of 
undifferentiation. 
MSCs from different parts of the placenta have been shown to differentiate into chondrogenic, 
osteogenic, endothelial, hepatocytic, myogenic and neurogenic lineages, but with appreciable differences 
among cell types depending on the placental tissue source [In't Anker et al., 2004; Sakuragawa et al., 
2004; Portmann-Lanz et al., 2006; Alviano et al., 2007; Pasquinelli et al., 2007; Soncini et al., 2007; 
Tamagawa, 2007; Kobayashi et al., 2008; Tamagawa et al., 2008; Mihu et al., 2009; Wei et al., 2009; 
Chang et al., 2010; Insausti et al., 2010]. The ability of hAECs to differentiate into cardiomyocytic, 
myocytic, osteocytic, adipocytic (mesodermal), pancreatic, hepatic (endodermal), neural, and astrocytic 
(neuroectodermal) cells in vitro has been established [Miki et al., 2005, 2007; Ilancheran et al., 2007; 
Insausti et al., 2010]. In our study, we performed functional differentiation studies to identify which 
human amnion-derived cell population was associated with a greater capacity for mesodermal 
differentiation. We confirmed that, with stimulation, human amnion-derived cells will differentiate 
towards osteocytic, chondrocytic and adipocytic mesodermal lineages, indicating the presence of 
mesenchymal progenitors. However, we did observe some differences between the cell populations. 
hAMSCs showed higher adipogenic and chondrogenic potential, while hAECs showed more osteogenic 
differentiation capacity. Both populations retained the capacity to differentiate from culture passages P0 
to P4, as previously described for cells from the trophoblastic region of the placenta [Fukuchi et al., 
2004]. Importantly, although both populations showed similar cell-surface receptor expression patterns 
for mesenchymal progenitors, there were some differences in their differentiation potential. Our 
adipogenic differentiation results obtained with hAECs seems to be in contradiction to recent reports 
[Stadler et al., 2008]. It might be possible that the discrepancies in the published results with our ones 
could be due to the use of different cell populations with different differentiation potential [Stadler et al., 
2008]. In this regard, Portmann-Lanz et al. 2006 stated that their epithelial amniotic cells underwent a 
transient growth retardation during which morphology changed from a typically epithelial, cobblestone-
like morphology to the same fibroblast-like morphology observed with mesenchymal amniotic cells. In 
this regard, it has not yet been tested whether the change of morphology during hAECs cultivation 
originates from outgrowth of some rare hAMSCs probably present after isolation of hAECS, or from an 
epithelial to mesenchymal transition (EMT) of hAECs [Stadler et al., 2008]. 
The ability of isolated hAMSCs and hAECs to differentiate to mesodermal lineages was also assessed 
by qRT-PCR analysis. We studied RELs of the cytosolic fatty acid chaperone FABP4 [Xu et al., 2006], 
the LPL gene which is activated transcriptionally when pre-adipocytes differentiate into adipocytes 
[Enerbäck et al., 1992], and the APM1 gene which encodes a secretory protein of adipose tissue 
implicated in the pathogenesis of obesity [Schäffler et al., 1999]. These adipogenic-specific genes were 
expressed in hAMSCs, but not in hAECs, indicating that differentiation did not occur. 
Testing lineage-specific genes for osteogenesis, we examined an early marker for osteogenesis (ALP) 
and the gene OP that encodes for a glycoprotein expressed in bone [Zuk et al., 2002]. hAMSCs also 
showed the highest REL for osteogenic differentiation, although, unlike the results for adipogenesis, both 
populations were able to differentiate into osteocyte-like cells. Assaying chondrogenic differentiation, we 
found both populations able to differentiate towards chondrocyte-like cells, but hAMSCs showed stronger 
chondrogenic differentiation than hAECs, as reflected by their higher REL for Sox9 and Agg than 
hAECs. Overall, we found hAMSCs to have higher adipogenic and chondrogenic potential than hAECs, 
while both populations were equally capable of differentiating into osteocyte-like cells. In general, our 
results are in agreement with the findings of Bilic et al. 2008, who determined the quantity and quality of 
amnion cells following isolation and culture and postulated that hAECs were less reliable than hAMSCs 
as a source of MSCs. 
In conclusion, our data demonstrate the localization and successful isolation of both hAMSC and 
hAEC populations from HAMs. Both cell populations showed similar surface expression profiles of 
mesenchymal progenitors. However, they differed in cell yield and in differentiation potential to the main 
mesodermal lineages. Our functional differentiation studies demonstrated that hAMSCs appear to possess 
a much greater mesodermal differentiation capacity than hAECs, suggesting that hAMSCs contain more 
mesenchymal progenitor cells. These differences found in multi-lineage differentiation potential of both 
cell types must be taken into account when choosing the most appropriate cell type, hAMSCs or hAECs, 
for cell therapy to treat damaged or diseased tissues. 
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